These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10944)

  • 1. Bioavailability and dissolution of different formulations of oxytetracycline preparations.
    Hart A; Barber HE; Calvey TN
    Br J Clin Pharmacol; 1975 Jun; 2(3):277-80. PubMed ID: 10944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of oxytetracycline dihydrate tablets in dogs.
    Cooke RG; Knifton A; Murdoch DB; Yacoub IS
    J Vet Pharmacol Ther; 1981 Mar; 4(1):11-3. PubMed ID: 7349318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological availability and in vitro dissolution of oxytetracycline dihydrate tablets.
    Barber HE; Calvey TN; Muir K; Hart A
    Br J Clin Pharmacol; 1974 Oct; 1(5):405-8. PubMed ID: 22454918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and bioavailability of directly compressed oxytetracycline hydrochloride tablets.
    Aboutaleb AE; Tout SA
    Pharmazie; 1983 Mar; 38(3):186-8. PubMed ID: 6867079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bioavailability of diazepam from uncoated tablets in humans--Part I: correlation with the dissolution rates of the tablets.
    Ogata H; Aoyagi N; Kaniwa N; Koibuchi M; Shibazaki T; Ejima A; Tsuji S; Kawazu Y
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):159-65. PubMed ID: 7076345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of food on bioavailability of metronidazole from sugar-coated tablets having different dissolution rates in subjects with low gastric acidity.
    Ogata H; Aoyagi N; Kaniwa N; Ejima A
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):279-82. PubMed ID: 3733276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations, bioavailability and dissolution of chlorpropamide.
    Taylor T; Assinder DF; Chasseaud LF; Bradford PM; Burton JS
    Eur J Clin Pharmacol; 1977 Mar; 11(3):207-212. PubMed ID: 15845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution systems for chloramphenicol tablet bioavailability.
    Ogata H; Shibazaki T; Inoue T; Ejima A
    J Pharm Sci; 1979 Jun; 68(6):712-5. PubMed ID: 37318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmaceutical and biological availability of commercial preparations of furosemide.
    Stüber W; Mutschler E; Steinbach D
    Arzneimittelforschung; 1982; 32(6):693-7. PubMed ID: 6889429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-controlled release pseudoephedrine tablets: bioavailability and in vitro/in vivo correlations.
    Halsas M; Penttinen T; Veski P; Jürjenson H; Marvola M
    Pharmazie; 2001 Sep; 56(9):718-23. PubMed ID: 11593992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of the bioavailability of diazepam from uncoated tablets in beagle dogs with its dissolution rate and bioavailability in humans.
    Ogata H; Aoyagi N; Kaniwa N; Koibuchi M; Shibazaki T; Ejima A; Shimamoto T; Yashiki T; Ogawa Y; Uda Y; Nishida Y
    Int J Clin Pharmacol Ther Toxicol; 1982 Dec; 20(12):576-81. PubMed ID: 6818163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Microenvironmental pH Modulation on the Dissolution Rate and Oral Absorption of the Salt of a Weak Acid - Case Study of GDC-0810.
    Hou HH; Jia W; Liu L; Cheeti S; Li J; Nauka E; Nagapudi K
    Pharm Res; 2018 Jan; 35(2):37. PubMed ID: 29380076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of quinidine in slow-release form. A comparison between two preparations containing quinidine bisulphate as the active constituent.
    Regårdh CG; Johnsson G; Lundborg P; Perrson BA
    Arzneimittelforschung; 1977; 27(9):1716-8. PubMed ID: 21671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclodextrin multicomponent complexation and controlled release delivery strategies to optimize the oral bioavailability of vinpocetine.
    Ribeiro LS; Falcão AC; Patrício JA; Ferreira DC; Veiga FJ
    J Pharm Sci; 2007 Aug; 96(8):2018-28. PubMed ID: 17530626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
    Jantratid E; Prakongpan S; Amidon GL; Dressman JB
    Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
    Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
    Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials.
    Metzmann K; Schnell D; Jungnik A; Ring A; Theodor R; Hohl K; Meinicke T; Friedrich C
    Int J Clin Pharmacol Ther; 2014 Jul; 52(7):549-63. PubMed ID: 24755124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral formulations of adefovir dipivoxil: in vitro dissolution and in vivo bioavailability in dogs.
    Cundy KC; Sue IL; Visor GC; Marshburn J; Nakamura C; Lee WA; Shaw JP
    J Pharm Sci; 1997 Dec; 86(12):1334-8. PubMed ID: 9423141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo characteristics of some commercial phenobarbital tablets.
    Sylvestri MF; Ueda CT
    Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):492-7. PubMed ID: 528095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.